Prevalence and risk factors of HCV infection in Poland

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 12, 2011, Pages 1213-1217

  Flisiak, Robert ^a   Halota, Waldemar ^b   Horban, Andrzej ^c   Juszczyk, Jacek ^d   Pawlowska, Malgorzata ^b   Simon, Krzysztof ^e  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

anti hepatitis C virus; epidemiology; hepatitis C virus RNA; viral C hepatitis

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; BLOOD TRANSFUSION; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; POLAND; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE;

ADULT; BLOOD TRANSFUSION; FEMALE; HEALTH PERSONNEL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; POLAND; PREVALENCE; RISK FACTORS; RNA, VIRAL; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 80955167606     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834d173c     Document Type: Article

References (24)

1. Alter MJ. Epidemiology of hepatitis C infection. World J Gastroenterol 2007; 13:2436-2441.
2. Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29 (Suppl 1): 74-81.
3. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010; 14:1-21.
4. Negro F, Alberti A. The global burden of hepatitis C virus infection. Liver Int 2011; 31 (Suppl 2):1-3.
5. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31 (Suppl 2):30-60.
6. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48:148-162. (Pubitemid 350191999)
7. Bielawski K, Wlasiuk M, Truskolawska M, Falkiewicz B. HCV infection in Poland. Arch Med Res 2000; 31:532-535. (Pubitemid 32114187)
8. Braczkowska B, Kowalska M, Zejda JE, Beniowski M, Kulawik I, Kuleszyński J, et al. Prevalence and basic determinants of hepatitis C antibodies in medical students in Katowice, Poland. Przegl Lek 2006; 63:539-542.
9. Borzecka B, Błudzin W. The program of early detection of HCV infection. Przegl Epidemiol 2007; 61:733-738.
10. Chlabicz S, Bonifatiuk I, Radziwon P. Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland. Hepatol Res 2005; 33:206-210. (Pubitemid 41794208)
11. Seyfried H, Brojer E, Grabarczyk P, Rosińska M, Gronowska A, Letowska M. Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003. Przegl Epidemiol 2005; 59:807-814.
12. Flisiak R, Parfieniuk A. Investigational drugs for hepatitis C. Expert Opin Investig Drugs 2010; 19:63-75.
13. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M, Plotnikova V, et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 2001; 65:517-524. (Pubitemid 32959078)
14. Tallo T, Norder H, Tefanova V, Krispin T, Schmidt J, Ilmoja M, et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007; 79:374-382. (Pubitemid 46355436)
15. Ambrozaitis A, Zagminas KS, Balc IG, Widell A. Hepatitis C in Lithuania: incidence, prevalence, risk factors and viral genotypes. Clin Diagn Virol 1995; 4:273-284. (Pubitemid 26013331)
16. Viazov S, Kuzin S, Paladi N, Tchernovetsky M, Isaeva E, Mazhul L, et al. Hepatitis C virus genotypes in different regions of the former Soviet Union (Russia, Belarus, Moldova and Uzbekistan). J Med Virol 1997; 53:36-40.
17. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49:1335-1374.
18. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, et al. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008; 198:1337-1344.
19. Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR 2003; 52 (No. RR-3):1-13.
20. Brojer E. Serological and molecular markers of HCV infection in Polish blood donors. Przegl Epidemiol 2005; 59:511-517.
21. Contreras AM, Tinoco E, Celis A, Novelo B, Romero MV, Carrada E, et al. Hepatitis C antibody intraassay correlation: is retest in duplicate necessary? Transfusion 2007; 47:1686-1690. (Pubitemid 47300615)
22. Pham TNQ, Mulrooney-Cousins PN, Mercer SE, MacParland SA, Inglot M, Zalewska M, et al. Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection. JViral Hepatitis 2007; 14:537-548. (Pubitemid 47075430)
23. Chlabicz S, Flisiak R, Grzeszczuk A, Kovalchuk O, Prokopowicz D, Chyczewski L. Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland. World J Gastroenterol 2006; 12:141-145. (Pubitemid 43126101)
24. Chlabicz S, Flisiak R, Kovalchuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, et al. Changing HCV genotypes distribution in Poland-relation to source and time of infection. J Clin Virology 2008; 42:156-159.